Brief: Biocartis Says FDA Grants 510(K) Clearance For Septicyte® RAPID
30/11/2021 16:45
Nov 30 (Reuters) - Biocartis Group NV BCART.BR :
* BIOCARTIS GROUP NV: SEPTICYTE® RAPID RECEIVES 510(K)
CLEARANCE
BY US FDA
Source text for Eikon: ID:nGNE8pCmMZ
Further company coverage: BCART.BR
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Biocartis NV
See all newsBrief: Biocartis Group NV Appoints Randy Polonsky As Chief Financial Officer
Brief: Biocartis Appoints New Chief Business Officer, VP Global Marketing
Brief: Biocartis And Merck To Collaborate
Brief: Biocartis's Secured Creditors Enforced Their Security Over Subsidiaries Shares
Brief: Biocartis Announces Expansion Of Its Collaboration With Apis Assay Technologies